| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/30/2010 | WO2010108682A1 Salmonella enterica presenting c. jejuni n-glycan or derivatives thereof |
| 09/30/2010 | WO2010108400A1 Method for reconstructing tissue engineered human corneal endothelium |
| 09/30/2010 | WO2010108275A1 Method and apparatus for predicting susceptibility to a developmental disorder |
| 09/30/2010 | WO2010108232A1 Novel receptor hetero-dimers/-oligomers |
| 09/30/2010 | WO2010108215A1 Compounds and methods for modulating an immune response |
| 09/30/2010 | WO2010068418A3 Switchgrass biological containment |
| 09/30/2010 | WO2010062859A3 Recombinantly expressed plasmodium celtos antigen and methods of use thereof |
| 09/30/2010 | WO2010008587A3 A viral nucleocapsid protein as a multifunctional translation initiation factor and increased protein and polypeptide production using same |
| 09/30/2010 | WO2009120831A8 Novel n-and c-terminal substituted -antagonistic analogs of human gh-rh |
| 09/30/2010 | WO2009117622A3 Modified fgf-23 polypeptides and their uses |
| 09/30/2010 | US20100251433 Arcelin-5 promoter and uses thereof |
| 09/30/2010 | US20100251429 Novel protein, a gene encoding therefor and a method of using the same |
| 09/30/2010 | US20100251426 Extra-Cellular Matrix Localized Ferritin for Iron Uptake, Storage, and Stress Tolerance |
| 09/30/2010 | US20100251424 Plant regulatory sequences for selective control of gene expression |
| 09/30/2010 | US20100251416 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production |
| 09/30/2010 | US20100251396 Transgenic mice expressing human formyl peptide receptor |
| 09/30/2010 | US20100250600 Small Molecule Mimetics of Erythropoietin |
| 09/30/2010 | US20100249427 Bioluminescent protease assay |
| 09/30/2010 | US20100249378 Process of aqueous protein extraction from brassicaceae oilseeds |
| 09/30/2010 | US20100249377 ENGINEERED HYBIRD PHAGE VECTORS FOR THE DESIGN AND THE GENERATION OF A HUMAN NON-ANTIBODY PEPTIDE OR PROTEIN PHAGE LIBRARY VIA FUSION TO pIX OF M13 PHAGE |
| 09/30/2010 | US20100249376 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/30/2010 | US20100249372 Botulinum neurotoxin a receptor and the use thereof |
| 09/30/2010 | US20100249370 Process for the production of pramlintide |
| 09/30/2010 | US20100249034 Gfralpha3 and its uses |
| 09/30/2010 | US20100249033 Polymer factor ix moiety conjugates |
| 09/30/2010 | US20100249029 Peptides with high affinity for the prolactin receptor |
| 09/30/2010 | US20100249027 Crf conjugates with extended half-lives |
| 09/30/2010 | US20100249026 Albumin fusion proteins |
| 09/30/2010 | US20100249025 Peptide antagonists of vascular endothelial growth factor |
| 09/30/2010 | US20100249022 Strategy for cloning and expressing the extracellular domains of receptors as soluble proteins |
| 09/30/2010 | US20100249021 Method and medicament for inhibiting the infection of influenza virus |
| 09/30/2010 | US20100249016 Metal-binding compounds and uses therefor |
| 09/30/2010 | US20100248974 Crystal structure of cd147 extracellular region and use thereof |
| 09/30/2010 | US20100248360 Nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners |
| 09/30/2010 | US20100248355 Methods for generating high titer helper-free preparations of released recombinant aav vectors |
| 09/30/2010 | US20100248309 Thermostable alpha1-antitrypsin mutein with a disulfide bond and the method for preparing it |
| 09/30/2010 | US20100248305 Polyamino acid synthetase and gene encoding the same |
| 09/30/2010 | US20100248280 Method for Identifying a Compound that Modulates Telomerase Activity |
| 09/30/2010 | US20100248266 Purinergic (p2x) receptors in extra-cellular body fluid |
| 09/30/2010 | US20100248256 Hepatocellular carcinoma protein marker, and method for detection of hepatocellular carcinoma using the same |
| 09/30/2010 | US20100248255 Novel peptides |
| 09/30/2010 | US20100248241 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 09/30/2010 | US20100248240 Gene and protein relating to hepatocellular carcinoma and methods of use thereof |
| 09/30/2010 | US20100248234 Cancer diagnostic kit and cancer diagnostic method |
| 09/30/2010 | US20100248218 Conjugates, and use thereof in detection methods |
| 09/30/2010 | US20100247733 Plants and seeds of corn variety cv006790 |
| 09/30/2010 | US20100247710 Method for preparing food product |
| 09/30/2010 | US20100247681 Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes |
| 09/30/2010 | US20100247618 Novel synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV |
| 09/30/2010 | US20100247578 Carrier system for biological agents containing organosilicon compounds and uses thereof |
| 09/30/2010 | US20100247576 Nucleotide and amino acid sequences encoding an exported protein 1 derived from plasmodium vivax and uses thereof |
| 09/30/2010 | US20100247572 Viruses encoding mutant membrane protein |
| 09/30/2010 | US20100247571 Methods and compositions for immunization against virus |
| 09/30/2010 | US20100247569 Influenza A Virus Vaccines and Inhibitors |
| 09/30/2010 | US20100247562 Complexes Derived from Heterohybrid Cells and Uses Thereof |
| 09/30/2010 | US20100247561 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/30/2010 | US20100247560 Mutant botulinum neurotoxin serotype a polypeptide and uses thereof |
| 09/30/2010 | US20100247559 West nile virus vaccine, and method for production thereof |
| 09/30/2010 | US20100247553 Goodpasture Antigen Binding Protein |
| 09/30/2010 | US20100247542 Truncated variant of the mammalian target for rapamycin (mtor) protein |
| 09/30/2010 | US20100247529 Cooperative and dynamic assembly of affinity complexes |
| 09/30/2010 | US20100247522 Linked purine pterin hppk inhibitors useful as antibacterial agents |
| 09/30/2010 | US20100247520 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 09/30/2010 | US20100247518 Modified proteins, designer toxins, and methods of making thereof |
| 09/30/2010 | US20100247497 Vector particles for targetng cd34+ cells |
| 09/30/2010 | US20100247490 SIMIAN E ADENOVIRUSES SAdV-39, -25.2, -26, -30, -37, AND -38 |
| 09/30/2010 | US20100247482 Tight junction modulator peptides for enhanced mucosal delivery of therapeutic compounds |
| 09/30/2010 | US20100247457 Peptide-based tooth whitening reagents |
| 09/30/2010 | US20100247442 Macaca fascicularis ST2L |
| 09/30/2010 | US20100242358 Hypersensitive response induced resistance in plants by seed treatment |
| 09/30/2010 | DE102009014432A1 New nucleic acid, having gene cluster for synthesis of caprazamycin and comprising a fully defined base pair sequence, useful for biosynthesis of caprazamycin that is useful as antibiotic against gram positive bacteria e.g. Mycobacterium |
| 09/30/2010 | CA2757224A1 Salmonella enterica presenting c. jejuni n-glycan or derivatives thereof |
| 09/30/2010 | CA2756743A1 Novel receptor hetero-dimers/-oligomers |
| 09/30/2010 | CA2756596A1 Methods and compositions for the treatment of cirrhosis and liver fibrosis |
| 09/30/2010 | CA2756412A1 Compositions for stimulation of mammalian innate immune resistance to pathogens |
| 09/30/2010 | CA2756398A1 Combinations including pneumococcal serotype 14 saccharide |
| 09/30/2010 | CA2756313A1 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 09/30/2010 | CA2756206A1 Methods and compositions for immunization against virus |
| 09/30/2010 | CA2756168A1 Isoform nell-1 peptide |
| 09/30/2010 | CA2755983A1 Compounds and methods for modulating an immune response |
| 09/30/2010 | CA2755967A1 Nucleotide and amino acid sequences encoding an exported protein 1 derived from plasmodium vivax and uses thereof |
| 09/30/2010 | CA2755799A1 Method and apparatus for predicting susceptibility to a developmental disorder |
| 09/30/2010 | CA2753874A1 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding snf2 domain-containing polypeptides |
| 09/29/2010 | EP2233576A1 Modified coagulation factor VIIa with extended half-life |
| 09/29/2010 | EP2233575A1 An anti-hcv vaccine and preparation methods and uses thereof |
| 09/29/2010 | EP2233574A1 Mammalian cytokine: interleukin-B30 and related reagents |
| 09/29/2010 | EP2233572A2 Genes and polypeptides relating to human colon cancers |
| 09/29/2010 | EP2233571A1 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAS encoding the same |
| 09/29/2010 | EP2233568A1 Novel method for generation of RNA virus |
| 09/29/2010 | EP2233504A1 An erythropoietin mimetic peptide derivatives and its pharmaceutical salt, the preparation and uses thereof |
| 09/29/2010 | EP2233502A1 Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them |
| 09/29/2010 | EP2233498A1 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same |
| 09/29/2010 | EP2233497A2 Amylin family peptides and methods for making and using them |
| 09/29/2010 | EP2233496A1 Fluorescent proteins |
| 09/29/2010 | EP2233152A1 High growth reassortant influenza A virus |
| 09/29/2010 | EP2231861A1 Transgenic plants modified for reduced cadmium transport, derivative products, and related methods |
| 09/29/2010 | EP2231860A1 Polypeptide derived from protein a and able to bind pdgf |
| 09/29/2010 | EP2231857A2 Light-driven co2 reduction to organic compounds to serve as fuels or as industrial half products by an autotroph containing a fermentative gene cassette |
| 09/29/2010 | EP2231702A1 Protease inhibitor |
| 09/29/2010 | EP2231701A2 Peptidomimetics with glucagon antagonistic and glp-1 agonistic activities |